Flustop

Quick links to important sections

Flustop

Method of action: Analgesic

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flustop

Property Description
Active Ingredients Acetaminophen, Caffeine, Chlorpheniramine, Pseudoephedrine
Form Oral Dosage Form (Tablets/Capsules)
Pharmacological Class Analgesic, Antipyretic, Antihistamine, Decongestant
Common Use Symptomatic relief of cold and flu discomforts
Origin Synthetic Chemical Compounds

Flustop: A Multi-Symptom Cold and Flu Combination

Flustop is categorized as an oral fixed-dose combination (FDC) medicine, meaning it unites two or more active substances into a single dosage unit to simplify the management of symptoms. It is a well-known example of a quadruple-ingredient formulation targeting comprehensive symptomatic relief for upper respiratory tract ailments. This preparation is composed of synthetic chemical compounds and provides a broad-spectrum approach. Flustop is often marketed as an over-the-counter (OTC) product intended for the adult and adolescent patient group, specifically addressing the issue of cold-related fatigue through the inclusion of a stimulant.

What are the Active Ingredients in Flustop?

The medicine is formulated with four distinct active pharmaceutical ingredients (APIs), delivered in a single oral dosage form. These components are Acetaminophen (a non-aspirin analgesic and antipyretic), Pseudoephedrine (a sympathomimetic amine decongestant), Chlorpheniramine (a first-generation antihistamine), and Caffeine (a central nervous system stimulant). The specific combination of an antihistamine with a stimulant is clinically recognized for providing relief from allergic-type cold symptoms (runny nose, sneezing) while offsetting the potential for marked sedation associated with Chlorpheniramine.

General Purpose of the Quadruple-Ingredient Formula

The overall general purpose of the Flustop formula is to provide integrated symptom palliation, addressing the complex nature of cold and flu symptoms through one product. A typical use scenario involves managing the combination of a fever, headache, and significant nasal congestion that accompany a viral infection. The combination acts to relieve fever and minor body aches, clear obstructed nasal passages, reduce allergic-type symptoms like sneezing and rhinorrhea, and mitigate cold-related fatigue, supporting the patient's general well-being during the course of the upper respiratory tract ailment.

Regulatory References

  1. Cold and Cough Medicines - MedlinePlus

What side effects are possible with Flustop?

Possible Side Effects and Safety Information

The safety profile of Flustop is derived from the official regulatory data of its four active components, resulting in a structured risk assessment across several physiological systems.

Adverse Reaction Scope

Category Description based on Regulatory Documents
Frequency-Classified Reactions Officially documented effects range from Common (e.g., drowsiness, dizziness, dry mouth, insomnia, nervousness) to Rare (e.g., specific blood disorders, hallucinations).
System-Organ Classes Involved Adverse reactions are documented within Nervous System Disorders, Cardiac Disorders (palpitations, tachycardia), Vascular Disorders (hypertension), Gastrointestinal Disorders, and Hepatobiliary Disorders.
Serious Adverse Reactions Regulatory labels highlight the critical risk of Hepatotoxicity (severe liver damage) from Acetaminophen, particularly with high doses. Other serious documented risks include Severe Cutaneous Adverse Reactions (SCARs) and serious Cardiovascular Events (e.g., hypertensive crisis) linked to Pseudoephedrine.

Safety-Related Restrictions and Constraints

The official labeling includes specific contraindications that prohibit use in certain patient populations to manage known risks:

  • Pre-existing Conditions: The product is contraindicated in individuals with severe hepatic impairment, severe hypertension, severe coronary artery disease, or narrow-angle glaucoma.
  • Drug Interactions: Use is strictly restricted with or within 14 days of stopping a Monoamine Oxidase Inhibitor (MAOI), due to the potential for a dangerous drug interaction.
  • Population Notes: Older adults are noted to have increased susceptibility to central nervous system effects (sedation, confusion) and urinary retention.

Regulatory Safety Summary

The safety profile establishes the potential for both common, dose-dependent side effects and serious adverse reactions. The classification of effects, along with explicit restrictions against use in severe hepatic or cardiovascular conditions, formally defines the boundaries for the medicine's safe use as documented by government regulatory authorities.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Flustop overdose is defined by the acute effects of its CNS-active components and the potential for delayed, severe organ damage from Acetaminophen. Documented initial manifestations may include non-specific gastrointestinal signs such as nausea, vomiting, and general malaise.

Acute CNS and cardiovascular effects are listed, presenting as confusion, restlessness, insomnia, tremor, increased blood pressure (hypertension), and tachycardia. Severe manifestations include seizures and life-threatening outcomes such as hemorrhagic stroke and acute myocardial infarction.

The most critical documented risk is the potential for delayed, potentially fatal hepatic necrosis (severe liver damage), which may not present clinical or laboratory evidence until 48 to 72 hours post-ingestion. Due to this delayed toxicity, regulatory documents mandate that immediate medical help must be sought or Poison Help contacted right away, even if the individual appears well. Prompt medical attention is critical.

Management procedures involve supportive treatment and monitoring. N-acetylcysteine is the specific antidote for the Acetaminophen component. Increased risk of hepatotoxicity is officially noted for patients with pre-existing liver disease or chronic alcohol consumption.

Therapeutic Uses of Flustop

What Flustop treats: Main Uses and Benefits

Flustop is a combination medicine, and its primary therapeutic domain is the symptomatic treatment of common cold and flu. This medicine generally contains a mix of ingredients that contribute to easing the overall symptom load associated with these temporary physiological imbalances.

Combination products in this category are commonly used across conditions presenting with acute episodes. The medicine provides supportive relief when symptoms become more noticeable, addressing symptoms that create noticeable physiological strain and those that interfere with daily functioning. Specifically, the medicine helps with managing headache, body aches, fever, nasal congestion, stuffy nose, runny nose, watery eyes, and sneezing.


The approach is generally relevant when short-term symptomatic assistance is needed. This combination approach helps patients cope more steadily with symptom fluctuations during acute episodes, supporting general well-being during symptomatic phases.

Quick Fact: Supports Easing Nasal Congestion

Regulatory References

  1. Health Canada guidance on cough, cold, flu medicines

Eligibility and Restrictions for Use

Who can and cannot use Flustop?

This medicine is officially approved for adults and adolescents aged 12 years and older. Eligibility is strictly defined by the risk profile of its four active ingredients.

Flustop is Contraindicated (Must Not Be Used) in:

  • Patients with severe hypertension or severe coronary artery disease.
  • Patients with severe hepatic impairment (severe liver disease).
  • Patients with known hypersensitivity to any component.
  • Patients currently using or who have used a Monoamine Oxidase Inhibitor (MAOI) within the last 14 days.

Population Group Official Eligibility Status
Children under 12 years Contraindicated/Not Recommended (Safety not established for combination products)
Older Adults (Geriatric) Use with Caution (Increased risk of cardiovascular and CNS effects)
Pregnancy/Lactation Not Recommended (Contraindicated in 3rd trimester; ingredients transfer to breast milk)
Comorbidities Use with Caution for Diabetes Mellitus, Hyperthyroidism, Narrow-Angle Glaucoma, and conditions causing urinary retention

What should I know about interactions with other medicines?

Flustop is a combination product whose interaction profile is defined by its individual active components (Paracetamol/Acetaminophen, antihistamine, decongestant, and caffeine).

Interaction-Related Restrictions

Restriction Category Constraint or Requirement
Additive Toxicity Do Not Combine with any other product containing Paracetamol/Acetaminophen or Caffeine to avoid exceeding maximum daily limits and prevent organ toxicity.
CNS Depression Avoid consuming Alcohol (Ethanol), as this may dangerously increase the sedative effects of the antihistamine component. Caution is required when using with other Central Nervous System (CNS) depressants, such as sedatives or tranquilizers.
Hypertensive Effects Consult a Doctor before use if taking prescription medicines for high blood pressure (antihypertensives), as the decongestant component may reduce their effectiveness or increase the risk of cardiovascular effects.
MAO Inhibitors (MAOIs) Avoid concurrent use with Monoamine Oxidase Inhibitors (MAOIs), or within two weeks of stopping MAOI therapy, due to the high risk of severe hypertensive crisis resulting from the decongestant component.

Co-administration with other sympathomimetic amines (e.g., other decongestants, appetite suppressants, or psychostimulants) is officially advised against due to the combined risk of cardiovascular side effects. Additionally, the antihistamine component may have additive antimuscarinic effects when used with other anticholinergic drugs, such as tricyclic antidepressants.

Mechanism of Action

Pharmacodynamic Mechanism: Adrenergic Modulation

Flustop's primary mechanism is centered on the sympathetic nervous system through its action as an agonist on alpha1-adrenergic receptors . These receptors are located on the smooth muscle of peripheral arterioles, particularly within mucosal tissues. Receptor binding initiates a Gq protein cascade, which increases the intracellular concentration of calcium ions ( Ca^2+). This surge in Ca^2+ directly causes the contraction of vascular smooth muscle cells and leads to the physiological consequence of local vasoconstriction and decreased blood volume in the targeted tissue.

Flustop also acts as an inhibitor of the norepinephrine reuptake transporter (NET). By impeding the removal of native norepinephrine from the synaptic cleft, it elevates the neurotransmitter's concentration, reinforcing the alpha-adrenergic signaling. A secondary mechanistic side-cascade involves non-selective stimulation of beta1-adrenergic receptors in the heart, leading to increased Ca^2+ and resulting in the systemic effect of increased chronotropy (heart rate) and inotropy (force of contraction).

Dosage and Administration Information

How to Use Flustop: Official Administration Guidelines

This map formalizes the high-level usage instructions for the Flustop quadruple-ingredient combination (Acetaminophen, Caffeine, Chlorpheniramine, Pseudoephedrine).


Administration Scope

The approved route of administration for Flustop is oral, typically delivered as a tablet or capsule. The dosing schedule for adults and children 12 years of age and older is typically one to two dosage units per administration. This dose is taken every 4 to 6 hours as needed for symptoms. Guidelines set an absolute maximum, dictating that the total intake must not exceed four to six doses within a 24-hour period. The medicine may be taken with or without food and must be swallowed whole with fluid; it should not be crushed, chewed, or dissolved.

Age-Group Administration and Special Conditions

Administration is designated for individuals 12 years of age and older. Use in children under 12 years is not authorized without professional consultation. To minimize the potential for sleep interference due to the stimulating components, the last dose of the day should be taken several hours before bedtime. Flustop is designated exclusively for short-term symptomatic use, and continuous administration must not exceed 7 days. Since the medicine is taken only as symptoms require, a scheduled fixed regimen is not applicable.


Resulting Procedural Structure

The official usage protocol requires the oral administration of the fixed unit, adherence to the specific 4-to-6-hour interval, and strict compliance with the total 24-hour dose ceiling. This structured approach defines the required administration pattern for the medicine.

Recent Clinical Evidence

Flustop: Recent Clinical Evidence

Evidence for Multi-Symptom Relief in Adults

Research concerning this fixed-dose combination, which contains an analgesic, decongestant, antihistamine, and stimulant, has primarily evaluated adults presenting with the common cold or flu-like illness. The scientific understanding relies heavily on Randomized Controlled Trials (RCTs). These studies randomly assigned adult volunteers to receive either the combination medicine, a placebo, or sometimes a single active ingredient.

Researchers focused on global symptom scores—measurements used in research exploring how overall symptoms evolve over time, aggregating issues such as headache, body aches, and nasal obstruction. Studies also monitored individual patient-reported outcomes describing perceived discomfort and outcomes capturing phases of heightened symptom activity (runny nose, sneezing).

Study Comparisons and Evidence Gaps

When evaluated in research, measurements were compared against controls, including the placebo and single-active components, to contextualize patient-reported experiences. The overall evidence for symptomatic relief in adults is generally categorized as Moderate to High by scientific reviewers, reflecting a solid research foundation for the individual drug classes (e.g., analgesic, decongestant).

Research duration is limited: studies mainly track effects over a single dose (4 to 6 hours) or a short course (up to 2 to 7 days). Long-term effects are not fully established. Furthermore, data for certain groups remain insufficient; research primarily applies to healthy adults, and studies evaluating this specific multi-ingredient formula's patterns of use in young children (under age 12) are insufficient according to authoritative guidance.

Key Studies & References Non-prescription Oral Adult Cough, Cold and Flu Labelling Standard - Health Canada

Frequently Asked Questions (FAQ)

Common questions about Flustop (FAQ)

Q: How quickly should I expect Flustop to start working?

Official product information for the active components indicates that effects are generally reported to begin shortly after administration. Key ingredients, such as Acetaminophen and Pseudoephedrine, typically start to take effect within about 15 to 30 minutes.


Q: Can Flustop be taken on an empty stomach?

Yes, according to official administration guidelines, Flustop can be taken with or without food. The medicine should be swallowed whole with fluid.


Q: How long does the effect of a dose of Flustop typically last?

The medicine's effects are typically timed to align with the recommended dosing interval, which is every 4 to 6 hours for continued symptomatic relief. This interval is established in the official product information.


Q: Is it normal to feel a bit dizzy when first taking Flustop?

Yes, regulatory labels classify dizziness as a common side effect of this medicine. Due to the potential for central nervous system effects, caution is advised when performing tasks such as driving or operating machinery.


Q: Can people with kidney or liver issues typically use Flustop?

Regulatory information contraindicates the use of Flustop if you have severe liver impairment. Individuals with pre-existing liver or kidney conditions should consult a healthcare professional to determine if the medicine is appropriate for their use.


Q: Will Flustop still be effective if I take it late after symptoms start?

Regulatory information indicates the product is for symptomatic relief taken as needed; the official labeling does not address a reduction in effectiveness based on the duration of symptoms before the first dose.


Q: Is there a maximum number of days or doses Flustop should be taken?

Yes, official warnings state that intake should not exceed four to six doses within any 24-hour period. Furthermore, the medicine is designated only for short-term use, not to exceed 7 continuous days.


Q: How significant are the drug interactions reported with Flustop?

The reported drug interactions can be serious. For instance, the combination with MAO inhibitors is strictly prohibited due to a high risk of adverse reactions. The high risk of specific interactions means that reviewing all official warnings about prescription medicines and alcohol is important.


Q: Why is early administration of Flustop often emphasized?

Emphasis is placed on early administration so that the medicine can begin working promptly to relieve cold and flu discomforts. Taking it at the onset of symptoms allows the active ingredients to begin addressing discomforts like pain and congestion.


Q: Does Flustop affect sleep patterns?

Yes, official product information lists insomnia and nervousness as common side effects. To help mitigate the risk of sleep interference, regulatory guidance recommends taking the final dose of the day several hours before bedtime.


Q: Does Flustop help with fever as well as body aches?

Yes, one of the active ingredients in Flustop, Acetaminophen, is classified as both an analgesic (pain reliever for body aches) and an antipyretic (fever reducer). The combination is intended to treat both types of discomfort.


Q: Can Flustop cause any long-term health issues?

Flustop is authorized and intended only for short-term use, typically up to 7 days. The available regulatory evidence and clinical trials do not establish the safety profile for continuous, long-term use.


Q: What should I do if I miss a dose of Flustop?

Since this is an as-needed medicine, official guidance does not address a missed dose. If symptoms return, adhere to the recommended dosing interval and the maximum 24-hour dose limit before taking the next dose.


Q: Is Flustop commonly used in pediatric populations?

Official information states that the medicine is approved for adolescents 12 years of age and older. Its use is not authorized or recommended for children younger than 12 due to insufficient safety data for this specific multi-ingredient combination.


Q: Why does Flustop require a prescription?

The inclusion of the decongestant Pseudoephedrine subjects the product to federal and state regulations, which may restrict its sale to behind the counter or by prescription, depending on the jurisdiction.


Q: Can Flustop be used as a preventative measure?

No, official product information indicates that Flustop is designed and authorized only for the symptomatic relief of existing cold and flu discomforts, not for preventing illness.


Q: Are there common drug-drug interactions that people often overlook with Flustop?

Official warnings often emphasize the risk of accidentally combining this product with other products containing the same active ingredients, particularly Acetaminophen or Caffeine. It is crucial to check the labels of all other medicines being taken to avoid exceeding safe limits.


Q: What is the typical timeframe for someone to feel 'better' after starting Flustop?

Clinical trials for symptomatic relief products track the overall effectiveness of the medicine over a short course, typically 2 to 7 days, which is consistent with the authorized duration of use for Flustop.


Q: Can I take Flustop if I'm currently on a blood thinner?

Official regulatory information advises that individuals taking blood thinners (anticoagulants) should consult a healthcare professional before using Flustop. This caution is due to the components' potential for interaction or risk associated with increased bleeding.


Q: What if I experience mild nausea after taking Flustop, is that common?

Nausea is noted on the regulatory label as a possible side effect of the active components. While not always listed as a common effect, its occurrence is documented in the product's safety profile.


Q: Is Flustop designed to shorten the duration of the illness?

No, Flustop is classified as a symptomatic relief medication. Its purpose is to alleviate the symptoms of a cold or flu, such as fever, congestion, and aches, but it is not designed to shorten the duration of the underlying viral illness.


Q: What is the half-life of Flustop in the average adult?

Pharmacokinetic data is available for the individual active ingredients. For example, the half-life—the time it takes for half of the substance to be eliminated from the body—for a key component like Acetaminophen is approximately 2.5 hours in the average adult.


Q: Is Flustop suitable for generally healthy individuals?

Yes, Flustop is authorized for use in the general adult and adolescent population for short-term cold/flu symptom management, provided no specific contraindications are present.

How should Flustop be stored and disposed of?

How to Store and Dispose of Flustop (OTC Cold/Flu Combination)

Official regulatory guidelines mandate specific conditions to maintain the stability and safety of Flustop, a solid oral dosage form.

Required Storage and Protection

Requirement Specific Condition
Temperature Store at controlled room temperature (15 C to 30 C / 59 F to 86 F).
Environment Store in a cool, dry place, protected from excess moisture and heat. Do not store in the bathroom or freeze.
Container Keep the medicine in its original container and maintain the cap tightly closed.
Safety Must be stored out of the sight and reach of children at all times.

Disposal Requirements

Expired or unused Flustop must be handled via an approved community drug take-back program. If this option is unavailable, the medicine must not be flushed down a toilet or sink. The labeled procedure requires mixing the medicine with an unappealing substance, such as dirt or used coffee grounds, sealing the mixture in a bag, and discarding it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Flustop found in:

A-Z Index: